CBDNewsBreaks – EVIO, Inc. (EVIO) Expands into Canadian Cannabis Market
EVIO’s (OTCQB: EVIO) Canadian subsidiary, EVIO Canada, recently finalized a 50% acquisition of Keystone Labs, Inc., a Health Canada-licensed medical cannabis testing facility. An article discussing the company reads: “EVIO Inc. (OTCQB: EVIO) reached a significant milestone in its expansion plans in early May when its new subsidiary, EVIO Canada, announced its acquisition of a 50 percent stake in Keystone Labs, Inc., a licensed Canadian testing laboratory specializing in quality testing for regulated industries such as cannabis. In a May 3, 2018, news release announcing the deal (http://cnw.fm/npnJ9), William Waldrop, CEO and co-founder of EVIO, said Keystone Labs fits perfectly…






